Quest Diagnostics Debt/Equity Ratio 2010-2024 | DGX

Quest Diagnostics debt/equity ratio for the quarter ending September 30, 2024 was 0.83.

  • Quest Diagnostics average debt/equity ratio for 2023 was 0.64, a 0% increase from 2022.
  • Quest Diagnostics average debt/equity ratio for 2022 was 0.64, a 1.59% decline from 2021.
  • Quest Diagnostics average debt/equity ratio for 2021 was 0.63, a 3.08% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Quest Diagnostics Debt/Equity Ratio 2010-2024 | DGX

  • Quest Diagnostics average debt/equity ratio for 2023 was 0.64, a 0% increase from 2022.
  • Quest Diagnostics average debt/equity ratio for 2022 was 0.64, a 1.59% decline from 2021.
  • Quest Diagnostics average debt/equity ratio for 2021 was 0.63, a 3.08% increase from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.4B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$7B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$3.8B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.8B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$237M
Daxor (DXR)$46M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$11M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M